HRS-7535 Tablets

DRUG5 trials

Sponsors

Shandong Suncadia Medicine Co., Ltd.

Conditions

DiabetesObesityOverweightType 2 DiabetesType 2 Diabetes Mellitus

Phase 1

Pharmacokinetic and Safety Studies of HRS-7535 in Subjects With Moderate Renal Insufficiency and Healthy Subjects

CompletedNCT06132204

Shandong Suncadia Medicine Co., Ltd.Type 2 Diabetes

Start: 2023-12-21End: 2024-03-13Updated: 2024-10-15

Study on Drug Interaction of HRS-1780 Tablets, Henagliflozin Tablets, Metformin Tablets and HRS-7535 Tablets in Healthy Human

CompletedNCT06495931

Shandong Suncadia Medicine Co., Ltd.Type 2 Diabetes Mellitus

Start: 2024-07-15End: 2024-08-13Updated: 2026-04-24

Study on Drug Interaction of Metformin Tablets and HRS-7535 Tablets in Healthy Human

CompletedNCT06727838

Shandong Suncadia Medicine Co., Ltd.Diabetes

Start: 2024-12-31End: 2025-01-25Updated: 2026-04-24

A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight Subjects

CompletedNCT07269756

Shandong Suncadia Medicine Co., Ltd.Obesity, Overweight

Start: 2025-12-08End: 2026-03-08Updated: 2026-04-15

Phase 3

A Trial of HRS-7535 Tablets in Subjects With Overweight or Obesity

Active, not recruitingNCT06904105

Shandong Suncadia Medicine Co., Ltd.Obesity, Overweight

Start: 2025-04-09End: 2026-05-31Updated: 2025-06-22